Trial · NCT02606097
Registered outcomes38
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 38
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Overall clinical benefit rate | till 2 weeks after last dose | complete response (CR), partial response (PR), and stable disease (SD) |
| Secondary | Progression free survival (PFS) | till study end, estimated 3 years | |
| Secondary | Overall survival (OS) | till study end, estimated 3 years | |
| Other | Adverse events (AEs) | till 2 weeks after last dose | Incidence of AEs will be shown and severity will be graded using NCI-CTCAE version 4.0 |
| Other | Changes in clinical hematology laboratory result by hemoglobin (Hb) | till 2 weeks after last dose | (unit: g/dL) |
| Other | Changes in clinical hematology laboratory result by hematocrit (Hct) | till 2 weeks after last dose | (unit: %) |
| Other | Changes in clinical hematology laboratory result by platelet count | till 2 weeks after last dose | (unit: 10\^9/L) |
| Other | Changes in clinical hematology laboratory result by red blood cell (RBC) count | till 2 weeks after last dose | (unit: 10\^9/L) |
| Other | Changes in clinical hematology laboratory result by white blood cell (WBC) count | till 2 weeks after last dose | (unit: 10\^9/L) |
| Other | Clinical hematology laboratory result by WBC differential | till 2 weeks after last dose | (unit: %) |
| Other | Changes in clinical biochemistry laboratory result by potassium level | till 2 weeks after last dose | (unit: mmol/L) |
| Other | Changes in clinical biochemistry laboratory result by calcium level | till 2 weeks after last dose | (unit: mmol/L) |
| Other | Changes in clinical biochemistry laboratory result by glucose level | till 2 weeks after last dose | (unit: mmol/L) |
| Other | Changes in clinical biochemistry laboratory result by lactate dehydrogenase (LDH) level | till 2 weeks after last dose | (unit: U/L) |
| Other | Changes in clinical biochemistry laboratory result by blood urea nitrogen (BUN) level | till 2 weeks after last dose | (unit: mmol/L) |
| Other | Changes in clinical biochemistry laboratory result by creatinine level | till 2 weeks after last dose | (unit: mg/dL) |
| Other | Changes in clinical biochemistry laboratory result by total and direct bilirubin levels | till 2 weeks after last dose | (unit: mg/dL) |
| Other | Changes in clinical biochemistry laboratory result by albumin levels | till 2 weeks after last dose | (unit: g/L) |
| Other | Changes in clinical biochemistry laboratory result by alanine aminotransferase(ALT) levels | till 2 weeks after last dose | (unit: U/L) |
| Other | Changes in clinical biochemistry laboratory result by aspartate aminotransferase (AST) levels | till 2 weeks after last dose | (unit: U/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02606097/registered